Leontieva O V, Demidenko Z N, Blagosklonny M V
Department of Cell Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, USA.
Cell Death Dis. 2014 May 8;5(5):e1214. doi: 10.1038/cddis.2014.178.
Mammalian target of rapamycin (mTOR) is involved in insulin resistance (IR) and diabetic retinopathy. In retinal pigment epithelial (RPE) cells, insulin activates the mTOR pathway, inducing hypoxia-inducible factor-1α (HIF-1α) and HIF-dependent transcription in serum-free minimum essential medium Eagle (MEM). Serendipitously, we found that insulin failed to induce the HIF-1α-dependent response, when RPE cells were cultured in Dulbecco's modification of Eagle's medium (DMEM). Whereas concentration of glucose in MEM corresponds to normal glucose levels in blood (5.5 mM), its concentration in DMEM corresponds to severe diabetic hyperglycemia (25 mM). Addition of glucose to MEM also caused IR. Glucose-mediated IR was characterized by basal activation of mTORC1 and its poor inducibility by insulin. Basal levels of phosphorylated S6 kinase (S6K), S6 and insulin receptor substrate 1 (IRS1) S635/639 were high, whereas their inducibilities were decreased. Insulin-induced Akt phosphorylation was decreased and restored by rapamycin and an inhibitor of S6K. IR was associated with de-phosphorylation of IRS1 at S1011, which was reversed by rapamycin. Both short (16-40 h) and chronic (2 weeks) treatment with rapamycin reversed IR. Furthermore, rapamycin did not impair Akt activation in RPE cells cultured in normoglycemic media. In contrast, Torin 1 blocked Akt activation by insulin. We conclude that by activating mTOR/S6K glucose causes feedback IR, preventable by rapamycin. Rapamycin does not cause IR in RPE cells regardless of the duration of treatment. We confirmed that rapamycin also did not impair phosphorylation of Akt at T308 and S473 in normal myoblast C2C12 cells. Our work provides insights in glucose-induced IR and suggests therapeutic approaches to treat patients with IR and severe hyperglycemia and to prevent diabetic complications such as retinopathy. Also our results prompt to reconsider physiological relevance of numerous data and paradigms on IR given that most cell lines are cultured with grossly super-physiological levels of glucose.
雷帕霉素的哺乳动物靶点(mTOR)与胰岛素抵抗(IR)和糖尿病视网膜病变有关。在视网膜色素上皮(RPE)细胞中,胰岛素激活mTOR通路,在无血清的伊格尔最低必需培养基(MEM)中诱导缺氧诱导因子-1α(HIF-1α)和HIF依赖性转录。偶然发现,当RPE细胞在杜尔贝科改良伊格尔培养基(DMEM)中培养时,胰岛素未能诱导HIF-1α依赖性反应。MEM中的葡萄糖浓度与血液中的正常葡萄糖水平(5.5 mM)相对应,而其在DMEM中的浓度与严重糖尿病高血糖(25 mM)相对应。向MEM中添加葡萄糖也会导致IR。葡萄糖介导的IR的特征是mTORC1的基础激活及其对胰岛素的诱导性较差。磷酸化的S6激酶(S6K)、S6和胰岛素受体底物1(IRS1)S635/639的基础水平较高,而它们的诱导性降低。胰岛素诱导的Akt磷酸化降低,并通过雷帕霉素和S6K抑制剂恢复。IR与IRS1在S1011处的去磷酸化有关,雷帕霉素可使其逆转。雷帕霉素短期(16 - 40小时)和长期(2周)治疗均可逆转IR。此外,雷帕霉素不会损害在正常血糖培养基中培养的RPE细胞中Akt的激活。相比之下,托林1可阻断胰岛素对Akt的激活。我们得出结论,葡萄糖通过激活mTOR/S6K导致反馈性IR,雷帕霉素可预防这种情况。无论治疗持续时间如何,雷帕霉素在RPE细胞中均不会导致IR。我们证实,雷帕霉素也不会损害正常成肌细胞C2C12细胞中Akt在T308和S473处的磷酸化。我们的工作为葡萄糖诱导的IR提供了见解,并提出了治疗IR和严重高血糖患者以及预防糖尿病并发症(如视网膜病变)的治疗方法。鉴于大多数细胞系是在严重超生理水平的葡萄糖中培养的,我们的结果也促使人们重新考虑关于IR 的大量数据和范式的生理相关性。